Decoding Tumor–Immune Interactions
to Overcome Cancer Therapy Resistance
OUR RESEARCH
Our research focuses on understanding the complex interactions between cancer cells and the tumor microenvironment that shape tumor progression and therapeutic response. By integrating CRISPR-based functional genomics with experimental models and high-resolution single-cell and spatial profiling, we aim to identify tumor-intrinsic mechanisms that regulate anti-tumor immunity, tumor–immune interactions, and resistance to cancer therapy.
RESEARCH AFFILIATIONS
CONTACT
Cross Cancer Institute
University of Alberta
Edmonton, Alberta
Canada
Email: rmirzaei@ualberta.ca